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Effects of Human Cardiac Troponin T Mutations Associated with Cardio-
myopathy
Susan Nguyen, Jennifer Chen, Shannamar Dewey, Qian Xu,
Aldrin V. Gomes.
University of California, Davis, Davis, CA, USA.
Mutations in troponin, an important muscle protein complex, can result in car-
diomyopathy by interfering with the normal muscle activity of the heart. Tro-
ponin T (TnT) is the largest subunit of troponin and is involved in binding the
troponin complex to the thin filament. Investigation of two mutations associ-
ated with cardiomyopathy in TnT, I90M and R173Q, showed different physi-
ological characteristics. The TnT I90Mmutation was identified as the causative
agent of familial hypertrophic cardiomyopathy (FHC) in a large multi-genera-
tional Chinese family and at least two family members with this mutation died
of sudden cardiac death. Another mutation in TnT, R173Q, was identified as the
underlying cause of dilated cardiomyopathy (DCM). Patients with the TnT
R173Q mutation experienced prenatal onset DCM and supraventricular tachy-
cardia at a young age. Functional troponin complexes containing wild-type or
mutant TnT’s demonstrated similar maximal actomyosin ATPase activity. The
inhibitory ability of the troponin complexes containing the I90M mutation was
significantly reduced relative to wild-type TnT. Most RCM mutations investi-
gated to date showed a reduced ability to inhibit actomyosin ATPase activity
but the RCM mutation, R173Q, did not affect the inhibitory ability of troponin.
The mutations showed increased (I90M) and decreased (R173Q) calcium sen-
sitivity of actomyosin ATPase activity consistent with what has been observed
for most FHC and DCMmutations. The mutations reduced the rate of degrada-
tion of these proteins by calpain relative to wild-type TnT. Overall, these results
suggest that although calcium sensitivity may be an indicator of the type of car-
diomyopathy no clear trends in maximal or minimal ATPase activity exist that
can be used to characterize DCM and FHC mutations.
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Functional Consequences of a Novel Cardiac Troponin T Mutation Linked
to Infantile Restrictive Cardiomyopathy
Michelle S. Parvatiyar1, Shi Wei Yang2, Jose´ R. Pinto1, Michelle A. Jones1,
Jingsheng Liang1, Gregor U. Andelfinger2, James D. Potter1.
1Univ of Miami, Miller School of Medicine, Miami, FL, USA, 2CHU Sainte-
Justine Research Center, Montreal, QC, Canada.
A novel double deletion in cardiac troponin T (cTnT) of two highly conserved
amino acids (N100 and E101) was identified in the cardiac cDNA of a pediatric
transplant recipient. The patient previously presented with restrictive and hy-
pertrophic cardiomyopathy. Family work-up was negative, and she was found
to harbor a de novo mutation. Electron microscopy revealed the presence of
myofibrillar disarray and fibrosis. To further define this cTnT mutation as
a cause of the disease, functional studies were performed. Functional effects
of the single and double cTnT mutants (DN100, DE101 and DN100/DE101)
were analyzed in porcine skinned papillary muscle. Fibers were displaced
with exogenous cTnT mutants or WT, Ca2þ unregulated force was measured
and then reconstituted with binary cTnI.cTnC complex. The DN100 and
DE101 mutations showed opposing changes in the Ca2þ sensitivity of force de-
velopment compared to WT. The DN100 mutation increased this by 0.29 pCa
units and the DE101 mutation, in contrast, decreased it by 0.28 pCa units. In-
terestingly, the DN100/DE101 mutation shifted the Ca2þ sensitivity to the left
(þ 0.19 pCa units). This finding is compatible with the preserved systolic func-
tion in this patient. DE101 was the only mutation that decreased the maximal
force recovery compared to WT. In contrast, DN100 and DN100/DE101 did
not show significant changes in this parameter. Both DN100 and DN100/
DE101 exhibited decreased cooperativity of force development, suggesting al-
tered intra-filament protein-protein interactions. These data show that residue
N100 has a predominant effect over E101 and its absence is much more dele-
terious for cTnT function. In addition, the strength of the functional data vali-
dates this novel cTnT deletion mutant as the cause of this cardiomyopathy. Sup-
ported by NIH HL-42325(JDP), AHA 0825368E (JRP), AHA 09POST2300030
(MSP) and CIHR GMHD 79045 (GA).
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Biophysical and Biochemical Studies of Human Slow Skeletal Troponin T
Isoforms in Slow Skeletal Muscle
Michelle A. Jones1, Jose´ R. Pinto1, Qian Xu2, Aldrin V. Gomes2,
Michelle S. Parvatiyar1, Jingsheng Liang1, James D. Potter1.
1Univ of Miami, Miller School of Medicine, Miami, FL, USA, 2University of
California, Davis, Davis, CA, USA.
A paucity of information exists concerning the functional roles of the human
slow skeletal troponin T isoforms (HSSTnT isoforms) in different muscle
types. Three HSSTnT isoforms have been found in slow skeletal muscle:HSSTnT1 (þ Exons 5 and 12), HSSTnT2 (þ5, 12), HSSTnT3 (5, 12)
and HSSTnT4 (5,þ12, only found at the mRNA level). Soleus rabbit skinned
fibers were displaced with HSSTnT1, 2, 3 or 4 and reconstituted with human
SSTnI-C/STnC complex. The extent of Tn displacement was analyzed by mea-
suring the Ca2þ unregulated force (UF) at pCa 8.0 after SSTnT treatment. The
UF ranged from 63 to 73%. The Ca2þ sensitivity increased between SSTnT iso-
forms: isoform 1 (pCa50 ¼ 5.73) < isoform 2 (pCa50 ¼ 5.80) < isoform 3
(pCa50 ¼ 5.84). HSSTnT4 yielded a pCa50 ¼ 5.78. Using a reconstituted fast
skeletal muscle system, the actomyosin ATPase activity containing different
HSSTnT isoforms was determined. The HSSTnT isoforms did not alter ATPase
activation or inhibition in the presence or absence of Ca2þ. Potential interac-
tions between human cardiac troponin C (HcTnC), rabbit skeletal tropomyosin
(RsTm) and human cardiac troponin I (HcTnI) with SSTnT were mapped. Dot
blot analysis using HRP conjugated proteins revealed new interactions between
SSTnT peptides and HcTnC, RsTm and HcTnI. These results may help identify
the functional differences that occur between SSTnT isoforms due to their al-
ternative splicing. Supported by NIH HL-042325(JDP) and AR-050199 (JDP)
and AHA 0825368E (JRP).
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Does the DCM Functional Phenotype Predominate over that of HCM and
RCM?
Jose´ Renato Pinto, Erin Alexander, Michelle Jones, Jingsheng Liang,
James D. Potter.
Univ of Miami Miller School of Medicine, Miami, FL, USA.
In vitro investigations into Hypertrophic Cardiomyopathy (HCM) and Restric-
tive Cardiomyopathy (RCM) show that mutations in cardiac Troponin T (cTnT)
produce a pathogenic state via increase in myofilament Ca2þ sensitivity,
whereas mutations in cTnT that cause Dilated Cardiomyopathy (DCM) de-
crease Ca2þ sensitivity and maximal force. Our aim was to determine whether
combinatory mutations of an HCM, RCM and a DCM in cTnT yield an inter-
mediate or dominant functional phenotype that could be correlated with the
clinical condition seen in patients. Standard laboratory methods were used
for cloning, expression and purification of the WT and mutants: DK210
(DCM), I79N (HCM), DE96 (RCM), DK210/I79N, DK210/DE96 and DE96/
I79N. Porcine papillary skinned fibers were displaced with cTnTWT or mutant
and reconstituted with HCTnI-TnC. The Ca2þ sensitivity of force development,
maximal force and basal force were evaluated. The extent of TnT displacement
was analyzed by measuring the unregulated tension at pCa 8.0 after cTnT treat-
ment and none of the mutants showed an inability to displace the native cTn
complex. Both double mutants (DK210/I79N and DK210/DE96) containing
the DCM mutant showed a rightward shift in the Ca2þ sensitivity with a de-
crease in maximal force. In addition, the DK210 mutation rescued the impaired
relaxation produced by the RCMmutation (DE96). From the skinned fiber data,
DK210 has a dominant effect over I79N and DE96 mutations in cTnT. Circular
dichroism measurements demonstrated that all three double mutants had lower
alpha helical content than WT. In contrast, single mutants I79N (significantly)
and DK210 (showed a tendency) to increase alpha helical content. These results
suggest that cTnT can exist in multiple conformations that may be responsible
for these distinct functional phenotypes. NIH HL-67415 and HL-42325 (JDP),
AHA 0825368E (JRP).
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Cardiomyopathy-Causing Deletion K210 in Cardiac Troponin T Alters
Phosphorylation Propensity of Sarcomeric Proteins
Liliana S. Duke1, Mary L. Garcia-Cazarin1, C. Amelia Sumandea1,
Gail A. Sievert1, C. William Balke1, Dong-Yun Zhan2, Sachio Morimoto2,
Marius P. Sumandea1.
1University of Kentucky, Lexington, KY, USA, 2Kyushu University,
Fukuoka, Japan.
Ca2þ desensitization of myofilaments is indicated as a primary mechanism for
the pathogenesis of familial dilated cardiomyopathy (DCM) associated with the
deletion of lysine 210 (DK210) in cardiac troponin T (cTnT). DK210 knock-in
mice closely recapitulate the clinical phenotypes documented in patients with
this mutation. Considerable evidence supports the proposition that phosphory-
lation of cardiac sarcomeric proteins is a key modulator of function and may
exacerbate the effect of the deletion. In this study we investigate the impact
of K210 deletion on phosphorylation propensity of sarcomeric proteins. Quan-
titative analysis of cardiac myofibrils isolated from DK210 hearts identified
a decrease in basal phosphorylation of cTnI (46%), cTnT (29%) and MyBP-
C (31%) compared with wild type controls. Interestingly, immunoblot analyses
with phospho-specific antibodies show augmented phosphorylation of cTnT-
Thr203 (28%) and decreased phosphorylation of cTnI-Ser23/24 (41%) in mutant
myocardium. In vitro kinase assays indicate that DK210 increases phosphory-
lation propensity of cTnT-Thr203 three fold without changing cTnI-Ser23/24
Monday, February 22, 2010 353aphosphorylation. Molecular modeling of cTnT-DK210 structure reveals
changes in the electrostatic environment of cTnT helix (residues 203-224)
that lead to a more basic environment around Thr203, which enhances PKC-de-
pendent phosphorylation. In addition, yeast two-hybrid assays indicate that
cTnT-DK210 has enhanced binding to cTnI compared with cTnT-wt, and
may impair Ca2þ sensing/transmission leading to myofilament desensitization.
Collectively, our observations suggest that cardiomyopathy-causing DK210
has far-reaching effects influencing posttranslational modifications of key sar-
comeric proteins, and potentially cTnI-cTnT interaction.
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Em and Single Particle Analysis of Troponin at Low and High Ca2þ
Hyun Suk Jung1, Duncan Sousa2, Larry S Tobacman3, Roger Craig4,
William Lehman2.
1Korea Basic Science Institute, Daejeon, Republic of Korea, 2Boston
University School of Medicine, Boston, MA, USA, 3University of Illinois-
Chicago, Chicago, IL, USA, 4University of Massachusetts Medical School,
Worcester, MA, USA.
Crystal structures of the troponin ‘‘core-domain’’ formed in the presence and
absence of Ca2þ display a bilobed TnC subunit mounted on a semi-rigid scaf-
fold formed from major stretches of TnI and TnT. A central coiled-coil of TnI
and TnT is flanked by single TnI and TnT helices to form the W-shaped sup-
porting structure, which appears to be little changed by the binding of Ca2þ
(Takeda et al., 2003; Vinogradova et al., 2005). In contrast, at low Ca2þ, the
central helix joining C- and N-lobes of TnC melts, and the ‘‘regulatory’’ C-ter-
minal domain of TnI dissociates from the N-lobe of TnC (Vinogradova et al.,
2005). Consistent with biochemical studies, the C-terminal TnI sequences in
the thin filament are thought to latch onto actin and constrain tropomyosin in
the blocked state at low-Ca2þ. Their dissociation from actin at high-Ca2þ
and association with the N-terminal lobe of Ca2þ-saturated TnC may relieve
the constraint (Galinksa-Rakoczy et al., 2008). These conclusions remain un-
certain, however, because troponin is only semi-rigid (so crystal packing forces
may have influenced the structure) and the troponin complex used for crystal-
lization contained truncated subunits. Here we have studied isolated, intact tro-
ponin molecules using negative stain electron microscopy and single-particle
image processing. Averaged projection views and 3D reconstructions of the
isolated molecules show many of the same features seen in the crystal struc-
tures. Comparison of reconstructions of low and high Ca2þ data suggests that
the TnC N-lobe of cardiac troponin may be further from the core domain in
the EM than in the crystal structure.
Funding: HSJ (KBSI-T29760); NIH: WL (HL36153), LST (HL38834,
HL63774), RC (AR34711, RR08426).
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Nanobiology of the Cardiac Myofilament
Mathivanan Chinnaraj1, Wen-Ji Dong2, Herbert C. Cheung3,
John M. Robinson4.
1International Center for Public Health, Newark, NJ, USA, 2Washington
State University, Pullman, WA, USA, 3University of Alabama at
Birmingham, Birmingham, AL, USA, 4South Dakota State University,
Brookings, SD, USA.
The cardiac myofilament is a protein assembly that provides Ca-regulated force
development enabling the heart to undergo alternating periods of contraction
and relaxation. Troponin (Tn), a three-member protein assembly within the
myofilament, acts as a Ca-sensitive switch. Here, using single pair FRET in
freely diffusing assemblies of Tn, we show that Tn incompletely activates after
binding regulatory Ca. The reserved population of inactive Tn appears to func-
tion as a nanoscopic form of cardiac reserve that can be can be manipulated by
cell signaling mechanisms to fine-tune cardiac contractility. The results are dis-
cussed in terms of an energetic model of the cardiac myofilament.
1830-Pos
Investigating the Effect of Cardiomyopathy-Causing Mutations in Cardiac
Troponin-T on Calcium Buffering In Situ
Paul J. Robinson, Yin Hua Zhang, Barbara Casadei, Hugh Watkins,
Charles Redwood.
University of Oxford, Oxford, United Kingdom.
In vitro investigation of the effects of cardiomyopathy-causing mutations in
thin filament regulatory proteins has demonstrated that hypertrophic cardiomy-
opathy (HCM) and dilated cardiomyopathy (DCM) are caused by distinct pri-
mary alterations of cardiac contractility and myofilament calcium affinity. We
hypothesise that chronically altered calcium-buffering by mutant thin filaments
leads to altered calcium handling and, via calcium-dependent signalling path-ways, contributes to disease pathogenesis. We aim to study the in situ effect
on calcium flux of a HCM and a DCM causing mutation in human cardiac tro-
ponin T (cTnT) (R92Q, R131W respectively), by adenoviral mediated expres-
sion of mutant protein in adult guinea pig cardiomyocytes. The adenoviral vec-
tors co-express GFP and western blot analysis of FACS-sorted, GFP-expressing
cells showed that recombinant cTnT comprised 45-50% of the total cTnT in
these cardiomyocytes, 48 hours after infection. Analysis of unloaded sarcomere
shortening showed that at an excitation frequency of 2 Hertz, cardiomyocytes
infected with R131W cTnT elongated the time to 50% relaxation and reduced
the magnitude of contraction, whilst R92Q cTnT reduced the time to 50% re-
laxation and increased the contractile magnitude compared to wild type. Anal-
ysis of calcium transients of the same cells using fura-2 loading, indicates that
the R92Qmutation reduces calcium transient amplitude, whilst the R131Wmu-
tation increases the time to complete calcium reuptake, with no change to the
transient amplitude, despite the observed decrease in contraction. We are
currently assessing the caffeine transients of these cells to investigate alter-
ations to overall SR load and measuring alterations to components of cal-
cium-dependent signalling cascades which may link the acute effects of
cTnT mutations to macroscopic remodelling observed in the pathological dis-
ease states of HCM and DCM.
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The Small Molecule Smooth Muscle Myosin Inhibitor, CK-2018571, Selec-
tively Inhibits ATP Hydrolysis and Relaxes Smooth Muscle In Vitro
Sheila Clancy, Zhiheng Jia, Malar Pannirselvam, Xiangping Qian,
Bradley Morgan, Fady Malik, Jim Hartman.
Cytokinetics, Inc., South San Francisco, CA, USA.
Smooth muscle contraction is driven by cyclical, nucleotide-dependent changes
in myosin conformation that alter its affinity for actin, produce force, and gen-
erate movement. We used a high throughput screen to identify compounds that
inhibit the ATPase activity of smooth muscle myosin; optimization of the ini-
tial hit compounds has resulted in compounds with nanomolar affinity. A potent
representative of this chemical series, CK-2018571, inhibits the steady-state
ATPase activity of human smooth muscle myosin at low nanomolar concentra-
tions, approximately 10-fold lower than are required to inhibit non-muscle my-
osin, the most closely related myosin II. Selectivity between smooth and stri-
ated myosin IIs are >100-fold. Transient kinetic studies demonstrate that
CK-2018571 inhibits the myosin-catalyzed hydrolysis of the g-phosphate
group of ATP, with no effect on nucleotide binding or release from the enzyme.
Actin co-sedimentation assays indicate that CK-2018571 stabilizes a weak ac-
tin-binding conformation of myosin in the presence of ATP. Consistent with
this mechanism, CK-2018571 relaxes skinned rat tail artery muscle tissue at
low micromolar concentrations. Importantly, this relaxation occurs regardless
of whether the skinned muscle has been activated by calcium or by thiophos-
phorylation of the myosin regulatory light chain, supporting evidence that
CK-2018571 relaxes smooth muscle tissue by direct inhibition of activated
smooth muscle myosin. The ability of CK-2018571 to relax intact tracheal
smooth muscle and aortic ring preparations at micromolar concentrations sug-
gests this mechanism may prove useful in diseases of smooth muscle hyper-
contractility, such as hypertension and asthma.
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Direct Interaction between the C-terminus of the Myosin Light Chain
Phosphatase Targeting Subunit and Myosin Phosphatase-Rho Interacting
Protein
EunHee Lee1, Daivd B. Hayes1,2, Terence C. Tao1, Walter F. Stafford1.
1Boston Biomedical Research Institute, Watertown, MA, USA,
2MedImmune, Inc., Gaithersburg, MD, USA.
Both the Ca2þ signal and the alteration of the Ca2þ sensitivity of the contractile
apparatus regulate smooth muscle contraction. Myosin light chain kinase
(MLCK) phosphorylated the 20 kDa regulatory myosin light chain (MLC20)
resulting in contraction. Myosin light chain phosphatase (MLCP) dephosphor-
ylates MLC20 causing relaxation. Thus, the balance between the activities of
MLCK and MLCP determines the level of MLC20 phosphorylation.
MLCP consists of a 38 kDa catalytic subunit (PP1cd), a 110 kDa targeting sub-
unit (MYPT1), and a 21 kDa small subunit (M21). MYPT1 provides the sub-
strate specificity and the regulation of phosphatase activity. It was reported
that myosin phosphatase-Rho interacting protein (M-RIP) bound MYPT1 and
thus targeted MLCP to the actomyosin contractile filament based on yeast-
two hybrid and cell biological assays.
To determine if MYPT1 binds to M-RIP directly, we performed analytical ul-
tracentrifugation (AUC) study using purified peptides of MYPT1 and M-RIP.
